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Phosphatidic acid (PA) is the intermediate,
from which all glycerophospholipids are
synthesized. In yeast it is generated from
lyso-phosphatidic acid, which is acylated
by Slc1p, a sn-2-specific, acyl-Coenzyme
A-dependent 1-acylglycerol-3-phosphate
O-acyltransferase. Deletion of SLC1 is not
lethal and does not eliminate all
microsomal 1-acylglycerol-3-phosphate O-
acyltransferase activity suggesting that an
additional enzyme may exist. Here we
show that SLC4 (Yor175c), a gene of
hitherto unknown function, encodes a
second 1-acyl-sn-glycerol-3-phosphate
acyltransferase. SLC4 harbors a
membrane bound O-acyl transferase
(MBOAT) motif, and down regulation of
SLC4 strongly reduces 1-acyl-sn-glycerol-
3-phosphate acyltransferase activity in
microsomes from slc1 cells. The
simultaneous deletion of SLC1 and SLC4 is
lethal. Mass spectrometric analysis of
lipids from slc1 and slc4 cells
demonstrates that in vivo Slc1p and Slc4p
generate almost the same
glycerophospholipid profile. Microsomes
from slc1 and slc4 cells incubated with
[14C]-oleoyl-Coenzyme A in the absence of
lyso-phosphatidic acid and without CTP
still incorporate the label into
glycerophospholipids, indicating that
Slc1p and Slc4p can also use endogenous
lyso-glycerophospholipids as substrates.
However, the lipid profiles generated by
microsomes from slc1 and slc4 cells are
different and this suggests that Slc1p and
Slc4p have a different substrate specificity
or have access to different lyso-
glycerophospholipid substrates because of
a different subcellular location. Indeed,
affinity-purified Slc1p displays Mg2+-
dependent acyltransferase activity not only
towards lyso-phosphatidic acid but also
lyso forms of phosphatidylserine and
phosphatidylinositol. Thus, Slc1p and
Slc4p may not only be active as 1-
acylglycerol-3-phosphate O-
acyltransferases, but also be involved in
fatty acid exchange at the sn-2 position of
mature glycerophospholipids.
Introduction
All eukaryotes utilize glycerophospholipids
(GPL) to build their membranes and stock
triacylglycerols as an energy reserve when
nutrition is abundant. Both of these lipid
classes are made from phosphatidic acid
(PA), a central metabolite, which is taken by
several key enzymes into various pathways
(1). As shown in Fig. 1, PA can be
synthesized de novo through the acylation of
L-glycerol-3-phosphate by Gat1p or Gat2p
and subsequent acylation of the thus
generated lyso-PA by Slc1p, a lyso-PA
acyltransferase (LPAAT). Small variations of
this general pathway can be found in various
organisms: many eukaryotes including man
can synthesize 1-alkenyl-2-acylglycerol-3-
phosphate used for plasmalogen synthesis or
1-alkyl-2-acylglycerol-3-phosphate as
alternatives to 1,2-bisacylglycerol-3-
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phosphate. Also, the biosynthesis can start
form dihydroxyacetonphosphate instead of
glycerol-3-phosphate as depicted in Fig. 1.
Furthermore, yeast can also generate PA
through the breakdown of
phosphatidylcholine (PC) or
phosphatidylethanolamine (PE) operated by
phospholipase D (PLD) activities (2-5). PA
also acts as a general regulator of lipid
biosynthesis in yeast. This regulation is
achieved by PA’s ability to bind and
inactivate the transcriptional repressor Opi1p,
thereby allowing derepression of the
transcription of a large variety of lipid
biosynthetic enzymes when PA accumulates
(6).
SLC1 was first recognized as a 1-
acylglycerol-3-phosphate O-acyltransferase
in a screen for second site suppressor
mutations that would allow yeast to grow in
the absence of sphingolipids (7). This
seminal study showed that a suppressor effect
was due to a point mutation in SLC1, that this
gene encoded an LPAAT, and that the
suppressing gain of function SLC1-1 allele
allowed the enzyme to utilize C26:0 fatty
acids instead of the normal C18 species (7).
The fact that SLC1 was not essential and that
its deletion only eliminated about 60% of
microsomal LPAAT activity suggested that a
second, unrelated sn-2-specific LPAAT may
exist (8). Alternatively, the possibility was
not excluded that 1-acylglycerol-3-phosphate
may spontaneously transmute itself into 2-
acylglycerol-3-phosphate by acyl migration
and that the latter could be acylated in sn-1
by Gat1p/Gat2p, thus forming PA.
The two human SLC1 homologues LPAAT-
and LPAAT- have been demonstrated to
convert lyso-PA to PA and humans also
contain a third homologous gene, LPAAT-.
Similar to yeast, humans also harbor two
PI4,5P2-dependent, PC-specific PLDs, PLD1
and PLD2, which generate PA and are
activated by ARF, Rho GTPases, and some
PKCs (9). PA functions in multiple
pathways, it acts as a cofactor in Akt/mTOR
and Ras/Raf/Erk pathways, it activates
protein kinases (Raf-1 and PKC), protein
phosphatases (PP1 and SHP-1), and lipid
kinases such as sphingosine kinase 1 and
PI4P 5-kinase, it regulates the non-receptor
tyrosine kinase Fgr, plays an essential role in
exocytosis and endocytosis and has
numerous other signaling functions (9-12).
Importantly, LPAAT- is overexpressed in
some human cancers and specific inhibitors
of LPAAT- trigger apoptosis or necrosis of
tumor cells, indicating that LPAAT- plays
an important role in signaling pathways
critical to tumor cell survival (10).
In plants, PA increases in response to various
stresses, either through the activation of PLD
or of diacylglycerolkinase. Subsequently PA
acts on multitude of downstream signaling
pathways to elicit the stress response (12).
Recent work on the lipid remodeling of
glycosylphosphatidylinositol (GPI) anchors
in yeast showed that Gup1p is required for
the addition of a C26 fatty acid in the sn-2
position of GPI anchors (13). Gup1p harbors
a membrane bound acyl transferase motif
(MBOAT motif) present in a large variety of
acyltransferases of bacteria as well as
eukaryotes including man. Yeast also harbors
4 other MBOAT proteins, amongst which
Yor175c still has no known function. Here
we show that Yor175c, which we here name
SLC4, encodes a 1-acylglycerol-3-phosphate
O-acyltransferase that is partially redundant
with SLC1.
Experimental procedures
Yeast strains, media, reagents. Strains used
in this study are listed in Table IA. Cells
were grown on rich medium (YPD, YPG) or
defined media (SD, SG) containing 2%
glucose (D) or galactose (G) as a carbon
source and uracil (U), adenine (A) and amino
acids (aa) at 30°C (14, 15). Media contained
inositol unless indicated. Zymolyase 20T was
from Seikagaku Corporation (Tokyo, Japan),
lipids from Avanti Polar Lipids Inc.
(Alabaster, USA): 1-palmitoyl-2-hydroxy-sn-
glycero-3-phosphate, cat. number 857123P;
1-stearoyl-2-hydroxy-sn-glycero-3-
phosphate, cat. number 857128P; 1-
palmitoyl-2-hydroxy-sn-glycero-3-












phosphoethanolamine, cat. number 856705P;
1-oleoyl-2-hydroxy-sn-glycero-3-[phospho-
L-serine] sodium salt, cat. number 858143P.
[14C]-oleoyl-CoA (40-60 mCi/mmol cat.
number ARC-0527), [3H]-inositol (15-20
Ci/mmol, ART-116) and [3H]-serine (5-25
Ci/mmol, ART-246) were from ANAWA
trading SA (Wangen, Switzerland). EDTA,
triethanolamine, NaN3, sorbitol, K2HPO4,
KH2PO4, NaCl, lipid-free albumin, -
mercaptoethanol, leupeptin, chymostatin,
antipain and pepstatin were from Fluka
Chemie GmbH (Buchs, Switzerland). DNase
was from Seravac Biotech (Pty) Ltd.
(Eppindust, South Africa). Deoxycholate
sodium salt was from Merck (Darmstadt,
Germany). Calf intestinal phosphatase and
NEBuffer 3 were from New England Biolabs
Inc. (Frankfurt, Germany).
Construction of plasmids and strains. The
open reading frames of SLC4 and SLC1 were
amplified by PCR from genomic DNA using
primers containing rec1 and rec2 sequences.
The PCR amplified SLC4 and SLC1 open
reading frames were transfected into slc4
and slc1 cells, together with SalI digested
pGREG505 and pGREG546, respectively, to
generate pGAL1UAS-Yor175c and pGAL1UAS-
GST-SLC1 as described (16). In these
transfected strains, the remaining
chromosomal SLC1 and SLC4 genes were
knocked out by transfection of slc1::hphNT1
and slc4::LEU2 deletion cassettes generated
through PCR on plasmids pFA6a-hphNT1
(EUROSCARF) and pRS415 as templates,
respectively, thus producing strains 2.SLC4
and 2.SLC1. For plasmid pBF27 we







genomic DNA from strain 4R3. The
fragment was double digested with SpeI and
XhoI, ligated into p423Met25 and cloned in
the E. coli strain HB101 (17).
Preparation of microsomes. 100 ml of
YPDUA and/or YPGUA media were
inoculated with the appropriate strain to give
an A600nm of 0.01. After 24 h of growth at
30°C, cells were again diluted to an A600nm of
0.01. Cells were grown for additional 24 h at
30°C to reach an A600nm of 4 to 6. Cells (500
A600nm units of cells) were washed with 50 ml
ice-cold 10 mM NaN3, resuspended in 10 ml
zymolyase buffer (10 mM NaN3, 1.4M
sorbitol, 50 mM K2HPO4 pH 7.5, 40 mM -
mercaptoethanol, 0.4 mg/ml of zymolyase
20T) and incubated for 1 h at 25°C without
shaking. Spheroplasts were collected by
centrifugation at 800 g for 5 min at 4°C and
washed with one volume of zymolyase buffer
lacking -mercaptoethanol and zymolyase.
Spheroplasts were lysed in 10 ml lysis buffer
1 (0.2 M sorbitol, 1 mM EDTA, 10 mM
triethanolamine, pH 7.2, 1 μg/ml leupeptin, 2
μg/ml chymostatine, 2 μg/ml antipain, 2
μg/ml pepstatin) containing 0.2 mg/ml
DNase by vortexing 1 min, incubating on ice
during 10 min and vortexing one more min.
A centrifugation at 800 g for 5 min at 4°C
was performed to remove intact spheroplasts.
The supernatant was centrifuged at 30'000 g
for 30 min at 4°C to pellet the microsomes.
The supernatant was discarded, microsomes
were resuspended in 3 ml of lysis buffer 1
and 0.15 ml-aliquots were snap-frozen in
liquid nitrogen for storage at -80°C.
Purification of GST-Slc1p. FBY4142 cells
were grown overnight in SGaa to an A600 of 4
and 2000 A600 units of cells were digested
with 0.2 mg/ml Zymolyase as described
above. Washed spheroplasts were solubilized
at 4°C in 40 ml of lysis buffer 2 (20 mM
Tris-HCl, pH 7.5, 150 mM NaCl and
protease inhibitors as in lysis buffer 1)
supplemented with 1% Tween 20; lysis was
promoted by vortexing and rotation on a
wheel for 1 h. Insoluble material was
removed by centrifugation at 4°C (Sorvall
SS-34 rotor; 48'000 g x 15 min). The
supernatant was added to 0.5 ml of
MagneGST Glutathione Particles (Promega,
Madison, WI) and left on a rotating wheel for
1 h at 4°C. The particles were then washed
three times with lysis buffer 2 containing
0.1% of Tween 20 and eluted twice with 0.75
ml of the same supplemented additionally
with 10 mM reduced glutathione. Glycerol
was added to 25% and 10 aliquots of 0.2 ml
of eluate were frozen at -20°C. The eluate
contained 0.0125% of the protein loaded onto











increased the specific activity 400 fold.
LPAAT assay (acyl-Coenzyme A: 1-
acylglycerol-3-phosphate O-acyltransferase
assay). Stock solutions (1 mM) of 1-
palmitoyl-2-hydroxy-sn-glycero-3-
phosphate, 1-stearoyl-2-hydroxy-sn-glycero-
3-phosphate, lyso-PC, lyso-PE, lyso-PI or
lyso-PS were prepared in lipid buffer (150
mM NaCl, 10 mM K2HPO4/KH2PO4, pH 7.5
containing 1% lipid-free albumin). lyso-PI
was generated by treating PI with PLA2. For
the standard assay, reagents were added into
a 1.5 ml plastic tube on ice to a final volume
of 200 μl in the following order: 20 μl of
Tris/HCl 200 mM pH 7.5, water, 10 μl lyso-
PA (1-palmitoyl-2-hydroxy-sn-glycero-3-
phosphate) or lyso-GPL or lipid buffer, 2μl
of 2mM sodium meta-vanadate, sorbitol to a
final conc. of 0.2 M, microsomes
(corresponding to 20 μg of proteins unless
stated otherwise) and, after a preincubation
on ice for 10 min, 1 μl (0.02 μCi = 0.4 nmol)
of [14C]-oleoyl-CoA in 10 mM Na
acetate:ethanol (1:1). Tubes were incubated
at 25°C for indicated times. The
concentration of [14C]-oleoyl-CoA in the
standard assay amounts to approximately 1.2
mol%. To stop the reaction, 520 μl of CHCl3
and 260 μl of methanol were added to the
200 μl reaction mixture. After vigorous
shaking and 1-min centrifugation at 12’000 x
g, the lower organic phase was extracted 3
more times with upper phase from an
identical mixture of CHCl3/CH3OH/H2O
(26:13:10). The lower organic phase was
evaporated, resuspended in 30 μl of
CHCl3/CH3OH/H2O (10:10:3) and 15 μl
aliquots were spotted onto a TLC plate or
subjected to analytical treatments.
Microsomal assay of PI, PS and PE
biosynthesis. Frozen microsomes (20 μg
protein/assay), prepared as described above
were incubated in 1.5 ml plastic tubes, in a
final volume of 200 μl for 1 h at 25°C with
either [3H]-inositol (15 μCi/tube) or [3H]-
serine (34 μCi/tube), conditions being very
similar to the LPAAT assay. The standard
assay buffer contained in 20 mM Tris/HCl
pH 7.5, 200 mM sorbitol, 1 mM CTP, 2 mM
Mg2+, 0.1 mM oleoyl-CoA and 50 μm lyso-
PA (1-palmitoyl-2-hydroxy-sn-glycero-3-
phosphate) but no vanadate. Lipids were
extracted, desalted and analyzed by TLC in
solvent 1 (see below).
Assaying acyltransferase activity of purified
GST-Slc1p. Unless indicated otherwise, Tris-
HCl buffer, lyso-PA or lyso-GPLs or only
lipid buffer and vanadate were added into a
1.5 ml plastic tube on ice to a final volume of
200 μl in the same order and quantities as for
microsomal assays (see above). Further
additions were Tween 20 in water (0.08%
final conc.), 10 μl of 100 mM MgCl2, and
purified protein corresponding to 5 A600 units
of cells. After 5 min on ice, 2.5μl (0.05 μCi =
1.0 nmol) of [14C]-oleoyl-CoA were added
and tubes were incubated at 25°C for 120
min. Reactions were stopped as in
microsomal assays.
Analytical procedures and thin layer
chromatography. Lipid extracts were dried,
resuspended and sonicated for 30 seconds in
100 μl NEBuffer 3 supplemented with 0.1%
sodium deoxycholate. 20 U of calf intestinal
phosphatase were added and the mixture was
incubated at 37°C for 2 h. Phospholipase A2
treatment was done with 5 U of PLA2 during
2 h as described (18). GPLs were deacylated
in NaOH as described (19) for 1 h at 37°C
and desalted using CHCl3/CH3OH/H2O
partitioning as described above. Ascending
TLC on silica 60 gel glass plates was
performed with the following solvents:
solvent 1, CHCl3/CH3OH/0.25%KCl
(55:45:5), and solvent 2,
CHCl3/CH3OH/acetic acid/5% sodium
bisulfite (67:26:4.4:2.6). Radioactivity was
detected and quantified by two-dimensional
radioscanning using a Berthold radioscanner
or by exposing TLC plates to an image plate,
which was developed by the BIORAD
molecular Imager FX. Smith Waterman
scores were calculated at
http://pir.georgetown.edu/cgi-bin/pairwise.pl.
Mass spectroscopy analysis of lipid extracts.
Exponentially growing cells were harvested
when they reached an A600 of 2.0 and lipids
were extracted as described (20), using
procedure IIIB. At this stage an aliquot of a
similar lipid extract from wt cells grown in
[13C]glucose, supplemented with
[12C]inositol, was added as an internal












(16:16:5), heated to 65°C and stirred with a
rotating pistil (30,000 rpm). Aliquots
corresponding to 1 A600 unit of cells were
immediately injected into a PVA SIL HPLC
column (YMC Europe GmbH, D-46514
Scherbeck, Germany, 1 x 150 mm), which
was eluted at 45 μl/min. For elution, solvents
A, hexane-isopropanol (98:2); B, CHCl3-
isopropanol (65:35); C, CH3OH, all
containing 0.1% triethylamine (FLUKA
90335) and an equimolar amount of formic
acid were changed linearly over time to give
ratios A:B:C as follows: 0 min 70:30:0; 4
min 12:88:0; 10 min 9.8:74.2:16; 12 min
7.6:61.4:31; 14 through 20 min 0:0:100; 22
min 0:100:0; 26 through 33 min 70:30:0. Ions
in the effluent were ionized by electrospray
ionisation with an electrode potential of 3500
volt and the masses of negative ions were
detected by a Bruker Esquire-LC ion trap
mass spectrometer. The spectrometer
automatically fragments ions and records
secondary ions. This information is not used
routinely but has been used to confirm the
identity of signals while the method was
being set up. The sum of the signals of
selected internal 13C standard GPLs in each
lipid class (PI, PE, PS, PC,
phosphatidylglycerol (PG)) was utilized to
normalize the sum of signals from the
corresponding lipid class in the test sample in
order to make the ion counts for a given lipid
class (e.g. PI) obtained in different cell lines
directly comparable. (On the other hand, due
to different ionization efficiency, ion counts
obtained for different lipid classes (e.g. PI
and PC), do not allow to estimate the relative
abundance of the different lipid classes with
regard to each other.
Results
Synthetic effects of yor175c
In an attempt to find new LPAATs, we tried
to delete SLC1 in an are1 are2 gup1
gup2 yor175c quintuple mutant lacking all
5 MBOAT proteins of yeast. While the
quintuple mutant grew reasonably well, it
was impossible to delete SLC1 in this
background. Further investigation showed
that gup1 gup2 slc1 cells were perfectly
viable but that it was impossible to delete
SLC1 in a yor175c mutant. To test this
further we crossed a haploid slc1::KanMX4
with a haploid yor175c::KanMX4 strain,
sporulated the resulting diploid and analyzed
the progeny by dissecting tetrads
(supplemental Fig. S1A). In many tetrads less
than 4 spores were germinating, in all tetrads
producing 3 colonies, only two of them were
kanamycin resistant and in all tetrads
producing 2 colonies, none was kanamycin
resistant (supplemental Fig. S1A). At no
stage did we observe a difference in colony
size between wt and slc1 or slc4 single
mutants (not shown). Microscopic inspection
of plates showed that spores having failed to
produce colonies had germinated and
produced either two or four cells but no
more. These data are entirely compatible
with the view that the simultaneous presence
of both deletions in a haploid cell renders the
cell non-viable, i.e. that the two deletions are
synthetically lethal. Very bad growth of
slc1 yor175c double mutants, i.e. strong
synthetic sickness between these two
deletions has also been found in a recent
global genetic interaction study (21). In the
following we therefore will use SLC4 to
designate Yor175c. To generate viable
double mutants we transfected slc4 and
slc1 strains with centromeric plasmids
containing SLC4 and SLC1 under the GAL1
promoter, a promoter which initiates
transcription at a high rate when galactose is
present in the medium but which is repressed
in the presence of glucose. In slc4 and
slc1 strains containing SLC4 and SLC1 we
deleted remaining chromosomal SLC1 or
SLC4 genes. The resulting slc1 slc4 (2)
strains harboring a plasmid containing either
SLC1 or SLC4 (named 2.SLC1 and
2.SLC4) grew well not only in galactose-,
but also in glucose-containing liquid media
(supplemental Fig. S1B). The 2.SLC1 strain
also grew well on glucose-containing agar
plates (Fig. 2). Data suggest that low
amounts of either Slc1p or Slc4p made on
glucose media are sufficient for a relatively
normal cell growth. It however was
impossible to remove the GST-SLC1-
containing plasmid by counterselection on 5-
fluoroorotic acid, a compound which will kill
cells unless they loose the SLC1-bearing











that slc1 is synthetically lethal with slc4.
The data in Fig. 2 further shows that the gain
of function allele Slc1-1p can functionally
replace Slc1p and allows slc1 slc4 cells to
grow at a normal rate.
Microsomes of slc1 cells efficiently
transfer oleic acid to lyso-phosphatidic
acid
About 95 - 98% of the cellular glycerol-3-
phosphate acyltransferase, as measured by
the generation of lyso-PA from C18:1-CoA
and [14C]-glycerol, resides in microsomes, the
remainder being present in lipid bodies (8)
and this activity is encoded by GAT1 and
GAT2 (22). The incubation of microsomes
with C18:1-CoA and [14C]-glycerol allows
for the production not only of lyso-PA but
also of PA and such an assay thus
simultaneously measures glycerol-3-
phosphate acyltransferases and LPAATs (8).
Using this assay we found that microsomes
from 2.SLC1 and 2.SLC4 grown for two
days on glucose produced strongly reduced
amounts of PA in comparison to wt cells, but
that lyso-PA was still made (not shown). To
be able to measure sn-2 specific
acyltranferase independently from
Gat1p/Gat2p activity, we incubated
microsomes with [14C]-C18:1-CoA in the
absence or presence of lyso-PA (1-palmitoyl-
glycerol-3-phosphate or 1-stearoyl-glycerol-
3-phosphate)(23). In the absence of lyso-PA,
microsomes incorporated radioactivity into
lipids that comigrated either with PE, PI, PC
and PA standards or with free fatty acids and
diacylglycerol (DAG) standards (Fig. 3A and
B, lanes 1, 2, 5, 6). Interestingly, the
appearance of PA, PI and DAG was strong in
microsomes containing SLC1, whereas the
synthesis of PC and PE was strongly
dependent on Slc4p. The assay does not
contain CTP, serine or inositol and this
suggests that the labeled PI, PE and PC are
not made from endogenous lyso-PA, which
would get acylated to [14C]-PA and then
further processed, but that these GPLs arise
through direct acylation of lyso-GPLs, a
notion which is confirmed by another
experiment shown below (Fig. 6). The
addition of lyso-PA to the assay strongly
increased the accumulation of PA and
completely blocked the incorporation of label
into other lipids in slc4 (Fig. 3A, lanes 1 -
4) and 2.SLC1 (supplemental Fig. S2),
whereas GPLs continued to be made in
presence of lyso-PA in cells containing Slc4p
(Fig. 3A, lane 7; Fig. 3B, lanes 3, 7;
supplemental Fig. S2). Addition of lyso-PA
blocked the incorporation of label into other
lipids (PC, PI and PE), possibly by acting as
competitive inhibitor of potential lyso-GPL
substrates, since a large part of [14C]-oleate
(>70%) is consumed during the assay. As can
be seen in Fig. 3, panels A and B, the band
considered to be PA was sensitive to alkaline
phosphatase, while other species identified as
PE, PI and PC were not, as expected.
Alkaline phosphatase shifted the label of
[14C]-PA to a position corresponding to DAG
(Fig. 3A and 3B, lanes 4 and 8). As shown in
Fig. 3C, the lipids getting labeled in
microsomes of 2.SLC4 were susceptible to
mild alkaline hydrolysis, whereby the
released label migrated at a position
corresponding to [14C]-oleic acid and a
second, uncharacterized band of higher Rf
(Fig. 3C, lanes 1, 2, 5, 6). From lipids labeled
in the absence of lyso-PA, phospholipase A2
(PLA2) released the bulk of the radioactivity
as [14C]-oleic acid, but two relatively minor
lyso-GPLs carrying [14C]-oleic acid
presumably in the sn-1 position were also
generated (Fig. 3C, lanes 3, 4). In assays
done in the presence of exogenous lyso-PA,
almost all the label was released by PLA2
(lanes 7, 8), and thus had been incorporated
into the sn-2 position of lyso-PA.
SLC4 expression correlates with the 1-
acylglycerol-3-phosphate acyltransferase
activity in slc1 microsomes
To show that overexpression or depletion of
Slc4p influenced the LPAAT activity, the
kinetics of PA synthesis in microsomes from
2.SLC4 grown in galactose or glucose were
investigated. As shown in Fig. 4A, when
cells had been on glucose, one could observe
a linear increase in [14C]-PA up to 32 min. A
parallel increase of lipids migrating in the
region of GPLs containing PI, PS and PC and
of very apolar lipids migrating to the top of
the TLC plate (not shown) was equally











grown in galactose, the LPAAT activity was
so very strong that it had consumed most
[14C]-oleoyl-CoA already at time 0, i.e.
during the time elapsing between the addition
of radioactivity and addition of organic
solvent to stop the reaction (about 1 min), a
time during which reaction tubes were on ice.
Indeed, >70% of added radioactivity was
incorporated into PA at time 0. Thus,
overexpression of SLC4 on galactose media
led to much a higher activity than expression
on glucose media. As seen in Fig. 4B, lanes 1
- 3, decreasing the amount of microsomal
proteins from 200 to 2 μg increased overall
incorporation of radioactivity into lipid (by
23%), but high amounts of protein favored
the incorporation into GPLs. Non-saturating
concentrations of lyso-PA were also tested.
As seen in Fig. 4B, lanes 5 - 16 and the
corresponding quantification in Fig. 4C,
linear incorporation of radioactivity into PA
was observed during 15 min with wt
microsomes and lyso-PA concentrations of
0.05 and 0.5 μM while again, rapid saturation
was achieved at 50 μM lyso-PA. The
incorporation of label into GPLs and DAG
was not dependent on the concentration of
lyso-PA (Fig. 4B, lanes 5 – 13, not shown).
This can be rationalized by assuming that the
GPLs are made by the acylation of
endogenous lyso-GPLs. 50 μM of lyso-PA
seemed to be inhibitory for GPL biosynthesis
(Fig. 4B, lanes 14 - 16, Fig. 4C).
In the following we chose to compare
activities of different strains at 1 μM lyso-PA
corresponding to about 0.6 mol %. As shown
in Fig. 5A and the corresponding
quantification in Fig. 5B, the LPAAT activity
in 2.SLC4 microsomes was drastically
reduced when cells had been grown on
glucose during 48 h for depletion of Slc4
protein. It is worth noting that 2.SLC4 cells
grown on glucose had much less microsomal
LPAAT activity than wt cells, but
nevertheless grew normally (Fig. 5;
supplemental Fig. S1B). This suggests that
LPAAT in normal cells is not rate limiting.
On the other hand, when grown on galactose,
the acyltransferase activity of 2.SLC4
microsomes was as strong as the one of
microsomes from wt cells grown on glucose.
Significant amounts of radioactivity were
also incorporated into GPLs (PI, PS, and PC)
and this incorporation was significantly
enhanced when SLC4 was induced (Fig. 5B).
Phosphatidic acid generated by Slc1p and
Slc4p is utilized with similar efficiency in
microsomal PI, PS and PE biosynthesis.
To see if PA generated by Slc1p and Slc4p
could be further metabolized in various
biosynthetic pathways we modified the
microsomal system such as to contain CTP
and either [3H]-inositol or [3H]-serine. As
shown in Fig. 6, [3H]-inositol was
incorporated efficiently into PI whereby the
incorporation was totally dependent on CTP
and significantly enhanced by lyso-PA and
also somewhat better in the presence of
oleoyl-CoA. This suggests that the assay
allows for the incorporation of lyso-PA into
PI along the physiological route via PA and
CDP-diacylglycerol (CDP-DAG) (Fig. 1).
Similarly, when [3H]-serine was added
instead of [3H]-inositol, microsomes made PS
and PE in a CTP-, oleoyl-CoA- and lyso-PA-
dependent way (supplemental Figs. S4A, B).
Again, the synthesis of PS and PE was
dependent on CTP and strongly enhanced by
the presence of lyso-PA and oleoyl-CoA
(supplemental Figs. S4A, B). The absolute
CTP dependency of these assays
demonstrates that the PE, PI and PC species
observed in Fig. 3 could not be derived from
the processing of endogenous or exogenous
lyso-PA via CDP-DAG, because these assays
did not contain any CTP. We also found that
the addition of CDP-ethanolamine or CDP-
choline to microsomal assays containing
[14C]-oleoyl-CoA did not enhance the
labeling of PE and PC. We therefore
conclude that the PE, PI and PC species
observed in Fig. 3 were generated through
direct incorporation of [14C]-oleate into lyso-
PE, lyso-PI and lyso-PC. Moreover, the data
shown in Fig. 6 and Figs. S4A, B argue that
PA for microsomal PE, PI and PS
biosynthesis via CDP-DAG can originate
from either Slc1p or Slc4p, since microsomes
from all different cell lines generated
comparable amounts of these lipids.











fatty acid profile on glycerophospholipids
Lipid extracts were prepared from wt, slc1,
slc4, and 2.SLC1 and 2.SLC4 cells and
analyzed by HPLC-ESI-MS/MS. As shown
in Fig. 7A, total GPLs were slightly
decreased in slc1 and slc4 mutants but
overexpression of either Slc1p or Slc4p in
slc1 slc4 cells brought total ion counts
back to normal. Moreover, when all PA was
made by a single LPAAT, all cell types still
made each individual GPL species in
quantities amounting to at least 70% of the
normal amount present in wt (Fig. 7B). We
also found that all the lines shown in Fig. 7
made similar amounts of triacylglycerols
(supplemental Fig. S5), indicating that PA
made through both, Slc1p and Slc4p, was
metabolized to neutral fat.
Phosphatidylglycerol (PG), PI and PS are all
derived from CDP-DAG (Fig. 1), and, as
seen in Fig. 8A, the fatty acid profile of PI
and PG is quite similar. However, the
number of double bonds varies between PI
(and PG) on the one hand and other kinds of
GPLs on the other hand, since PI (and PG)
mostly contain one double bond, PE and PC
predominantly contain two double bonds, and
PS contains about equal amounts of species
with one and two double bonds in their fatty
acids (Fig. 8A). Our findings, made in cells
grown on galactose (YPGUA, at 30°C), are
in close agreement with the observations
made in a similar HPLC-ESI-MS/MS
analysis of the X2180 strain, grown on
glucose (YPD) at 24°C, results which are
reproduced for comparison in Fig. 8B (24).
In particular, in the biosynthetic pathway
leading from PS to PE and to PC (depicted
with thick arrows in Fig. 1) we see the same
relative decrease of 34:1 and parallel increase
of 32:2 species described before (24). These
findings are also in agreement with the
observation that the "normal" PE and PC
mostly contain an unsaturated fatty acid in
sn-1, especially when cells are grown in rich
medium as was the case in here (25). The
different fatty acid content between species,
which of course all derive from PA, suggests
a species-selective metabolism or exchange
of fatty acids on GPLs. Importantly, the
varying number of double bonds in different
GPL species observed in wt cells (Figs. 8A,
B) is equally seen in cells depending
exclusively on Slc4p (slc1, 2.SLC4; Figs.
8C, D) or exclusively on Slc1p (slc4,
2.SLC1; Figs. 8E, F). Furthermore, the
BY4742 as well as X2180 wt cells show a
tendency to have more PI, PS and PE species
with 34 C atoms than with 32 C atoms while
in PC the tendency is reversed (Figs. 8A, B),
and this feature again suggests some species-
selective metabolism or fatty acid exchange.
With regard to this phenomenon, a slight
difference is observed depending on the
LPAAT which is used by cells: Cells entirely
depending on Slc4p for PA biosynthesis
(slc1, 2.SLC4; Figs. 8C, D) show a
relatively higher percentage of PI, PS and PE
species with 32 C atoms than either wt cells
(Figs. 8A, B) or cells depending exclusively
on Slc1p (slc4, 2.SLC1; Figs. 8E, F). This
minor difference suggests that Slc4p may
have a better affinity for, or better access to
C16:1-CoA than Slc1p. Overall, the fatty
acid profiles in GPLs of all the strains are
surprisingly similar.
Characterization of GST-Slc1p
We tried to purify GST-tagged versions of
Slc1p and Slc4p. Purified GST-Slc4p had
only very low LPAAT activity. On the other
hand, purified GST-Slc1p was very active
and stable on storage at – 20°C. The partially
purified material contained a major band at
62 kDa, the expected molecular weight of
GST-Slc1p upon SDS-PAGE and staining of
gels with silver nitrate (Fig. 9A, lanes 1 - 2).
This band was below the detection level in
the starting microsomal extract (Fig. 9A,
lanes 3, 4) and could be stained with anti-
GST antibody (Fig. 9A, lanes 5, 6). The
purified GST-Slc1p generated PA from [14C]-
oleoyl-CoA, from which [14C]-oleate could
be released with PLA2 or mild base
treatments (not shown). As can be seen in
Fig. 9B, the activity of the purified enzyme
was dependent on the addition of lyso-PA
(lane 1 vs. 4) and was enhanced by the
presence of Mg2+ (lane 4 vs. 6), while other
divalent cations (Ca, Mn, Cu) had no effect
(not shown). Short term assays allowed to
calculate that Mg2+ enhanced the LPAAT
activity of GST-Slc1p 7 to 20 fold (Fig. 9C,
not shown). Yet, the acyl-Coenzyme A: 1-
acylglycerol-3-phosphate O-acyltransferase











slc4 cells was not enhanced by the addition
of Mg2+ (not shown). GST-Slc1p was slightly
more active with palmitoyl-sn-glycerol-3-
phosphate than with 1-stearoyl-sn-glycerol-3-
phosphate as a substrate (Fig. 9D, lanes 2, 5).
Boiling for 5 min destroyed the enzymatic
activity (Fig. 9B, lanes 4, 5).
GST-Slc1p can transfer acyls from CoA
onto lyso-glycerophospholipids
As mentioned, although all GPLs of yeast are
derived from PA, they contain different fatty
acids (24, 25) and metabolic labeling studies
have suggested that fatty acids on GPLs are
turning over with half lives that are
significantly shorter than the half live of
GPLs as measured in H32PO4
2- pulse chase
experiments (25-27). In view of the findings
of Figs. 3, 6 and S4, we were interested to
see if purified GST-Slc1p was able to
transfer fatty acids onto lyso-GPLs, i.e. if the
presence of a headgroup on the phosphate of
lyso-PA would hinder the interaction of the
substrate with the enzyme. As seen in Fig.
9D, in the presence of lyso-PA the purified
GST-Slc1p made PA and no other product,
but it made PC, PE, PS and PI in the presence
of the corresponding lyso-GPLs. The activity
was relatively weak with lyso-PC and lyso-
PE, but quite significant with lyso-PI and
lyso-PS (Fig. 9D). In the absence of Mg2+ the
acyltransferase activity with lyso-PI, lyso-PS
and lyso-PA was comparable (not shown). In
the presence of Mg2+ the activity was
enhanced only 2 fold with lyso-PI and lyso-
PS, but 7 to 20 fold with lyso-PA (Fig. 9C
and D, data not shown). Mg2+ may have to
shield the strong negative charge of lyso-PA
and therefore be more important for the
binding of this substrate than for binding of
lyso-GPLs to the enzyme. The data suggest
that Slc1p may be involved in the exchange
of fatty acids on GPLs in vivo and offer an
explanation for the labeling of GPLs with
[14C]-C18:1-CoA in the absence of CTP in
slc4 cells (Fig. 3A).
Discussion
Microsomes were reported to contain an
uncharacterized LPAAT, not related to SLC1
(8, 28). Here, we show that Slc4p can
account for this latter activity. The slc1 and
slc4 cells grow at normal rates and mass
spectrometric analysis reveals a quite normal
GPL profile in both, cells depending solely
on Slc1p and cells depending solely on Slc4p
(Fig. 8). A previous study also indicated that
slc1 cells have the same GPL profile as wt
apart from a reduction of a minor C12:0-
containing PI species (29). This data argues
that PA originating from either Slc1p or
Slc4p feeds into all lipid biosynthetic
pathways and suffices for all the essential
functions of a cell. In spite of this functional
redundancy, Slc1p and Slc4p are not
homologous to each other and have very
different structures. Indeed, Slc1p contains a
single transmembrane domain whereas 12
such domains are predicted for Slc4p.
It is likely that Slc4p itself harbors the
enzymatic activity, as it contains an MBOAT
motif, which has been found in many
ascertained acyltransferases (30). SLC4 also
contains the proposed active site residue,
which is His382. This His residue is the only
strictly conserved residue throughout this
large gene family and was recently shown to
be required for acyltransferase activity of
Gup1p, an yeast homologue of SLC4,
involved in lipid remodeling on GPI
anchored proteins (13, 30).
To date, all the known mammalian as well as
bacterial LPAATs are homologous to SLC1.
Yet, homologues of SLC4 are found in all
eukaryotes. The human genome harbors four
genes predicting proteins with about 30%
identity to SLC4, having Smith Waterman
scores between 500 and 660, and for which
no function is known. In comparison, the
four yeast homologues of SLC4 have scores
of 105 and below. Thus, it will be interesting
to investigate if the mammalian SLC4
homologs also have LPAAT activity. The
blast server at NCBI finds however no
homologues of SLC4 in bacteria.
Genetic data indicate that Slc1p and Slc4p
are not functionally exchangeable in all
respects. Indeed, slightly different roles for
Slc1p and Slc4p are suggested by the fact











influence the effect of other gene deletions
differently, i.e. that they display different
synthetic interactions: When combined with
either ric1 or rgp1 deletions, slc1 shows
synthetic sickness, whereas slc4 shows
synthetic enhancement (alleviation) (21). The
ric1 and rgp1 deletions affect nucleotide
exchange on Ypt6p, a G protein involved in
the vesicular retrotransport from the late
endosome to the Golgi.
Deletion of SLC4 eliminated the microsomal
biosynthesis of PE and PC, while deletion of
SLC1 reduced the biosynthesis of PA, PI and
DAG (Figs. 3A, 3B). Due to the absolute
CTP-dependence of the synthesis of these
GPLs in the microsomal system (Figs. 6 and
S4) we conclude that the labeling of PE, PI
and PC observed in the absence of CTP (Fig.
3A, B) proceeds from direct acylation of
lyso-GPLs. In confirmation, direct
acyltransfer onto lyso-PI and lyso-PS could
be demonstrated with purified Slc1p (Fig.
9D). In an earlier study, acyltransferase
activity in microsomes from slc1 cells,
overexpressing SLC1 or not, was measured
using [14C]-oleoyl-CoA and lyso-PI, lyso-PE
or lyso-PC as substrates (28). The
incorporation of [14C]-oleic acid into lipids in
these slc1 microsomes was strongly
dependent on the addition of exogenous lyso-
GPLs, but was only slightly stronger (10 to
20%) when SLC1 was overexpressed. Thus,
the bulk of activity was SLC1-independent.
Based on this and on the analysis of products,
the authors concluded that it was unlikely
that Slc1p itself was an acyltransferase for
lyso-PI, lyso-PE or lyso-PC (28). The use of
different assay conditions may have
prevented the detection of the lyso-GPL
acyltransferase activity of Slc1p in this
former study. As the lyso-GPL
acyltransferase activity of Slc1p seems to be
able to use lyso-forms of PI and PS but no
other lyso-GPLs as substrates (Fig. 9D), they
provide a reasonable explanation for the
relatively strong labeling of PI, but weaker
labeling of PC and PE in microsomes of
slc4 cells (containing only Slc1p)(Fig. 3A,
lane 1 versus 5). The specificity of Slc1p for
PI and PS may also provide part of the
explanation as to why in lcb1 SLC1-1 cells
C26:0 fatty acids get incorporated
specifically into PI and not into all other
GPLs as well (7).
Exchange of fatty acids of GPLs (lipid
remodeling) is a well-established
phenomenon in yeast (27). In plants and
yeast, the acylation of lyso-GPLs may be
important to metabolize the lyso-PE and lyso-
PC, which are generated by phospholipid-
DAG-acyltransferases (PDAT) such as
scLRO1 or AtPDAT1. These enzymes
transfer fatty acids from PE and PC onto
DAG to generate triacylglycerols. Similar
enzymes transfer fatty acids from GPLs onto
sterols or act as phospholipase A1 and
thereby also generate lyso-GPLs (31-33).
Several studies have reported on enzymatic
activities or specific enzymes of yeast able to
reacylate the sn-2 position of lyso-PC (28,
34-37). Purified Plb1p, a phospholipase B,
was shown to be capable of transferring
[14C]-C16:0 from 1-[14C]-palmitoyl-sn-
glycerol-3-phosphorylcholine onto the sn-2
position of the same lipid in a CoA-
independent manner (34, 35). A similar
activity has been described for Taz1p. Taz1p
is homologous to the human tafazzin, the loss
of which causes a congenital myo- and
neuropathy (Barth syndrome)(37). Plb1p and
Taz1p, however, are located in the plasma
membrane and the outer mitochondrial
membrane, respectively, and do not need
acyl-CoA. Acyl-CoA dependent lyso-GPL
acyltransferase activities have been measured
in yeast microsomes before (28, 36). Some of
our data suggest that not only Slc1p but also
Slc4p may contribute to this lyso-GPL
acyltransferase activity. Indeed, the
generation of labeled PE, PI and PC in
presence of [14C]-oleoyl-CoA was
significantly enhanced in microsomes
overexpressing Slc4p as compared to
microsomes carrying physiological levels of
Slc4p (Fig. 3A, lanes 7, 8 vs. Fig. 3B, lanes
7, 8). This suggests that Slc4p, as Slc1p, has
the capacity to transfer oleate from [14C]-
oleoyl-CoA onto certain lyso-GPLs. The fact
that not exactly the same lyso-GPLs are
acylated in Slc1p- and Slc4p-containing
microsomes may be due to differences in
substrate specificity or subcellular
localization of the two enzymes. While Slc1p
has been localized to the ER and lipid bodies,
two global proteome localization studies
have failed to produce any data for Slc4p
((8); http://ypl.uni-graz.at/pages/home.html).












phosphorylcholine acyltransferase activity of
slc1 microsomes is provided by Slc4p and
if this function is physiologically relevant.
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Condensed title: SLC4 encodes an acyltransferase
Key words not in title: LPAAT, phosphatidic acid, lipid biosynthesis, lipid remodeling,
endoplasmic reticulum, Saccharomyces cerevisiae
Abbreviations: DAG, diacylglycerol; FOA, 5’-fluoroorotic acid; GPL, glycerophospholipid;
LPAAT, lyso-phosphatidic acid acyltransferase; PA, phosphatidic acid; PC,
phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; PI,
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Figure 1. Biosynthesis and breakdown of phosphatidic acid in Saccharomyces cerevisiae.
Enzymes required for the generation of GPLs from diacylglycerol (DAG) and CDP-DAG are
not indicated. CL, cardiolipin; DAG-PP, DAG-pyrophosphate; DHAP, dihydroxyaceton-
phosphate; Gro3P, glycerol-3-phosphate; PAK, PA kinase; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PG, phosphatidylglycerol; PGP, PG-phosphate; PI,
phosphatidylinositol; PS, phosphatidylserine; TG, triacylglycerol.
Figure 2. slc1 slc4 cells are not viable.Wt (BY4742), slc1, slc4, and four different slc1
slc4 double mutant strains harboring either GST-SLC1 on an URA3 vector or SLC1-1 on a
HIS3 vector were plated at ten fold dilutions on SDaa or SDaa plus 5'-fluoroorotic acid (FOA),
and incubated at 30°C for 3 days.
Figure 3. Microsomes from wt (BY4742), slc1, slc4, and 2.SLC4 cells make phosphatidic
acid from 1-acylglycerol-3-phosphate.Microsomes were prepared from cells growing
exponentially in YPGUA. A, B, Microsomes were incubated with [14C]-oleoyl-CoA in the
presence (+) or absence (-) of lyso-PA (50 μM) for 120 min. After incubation, lipids were
extracted and were incubated in the presence (+) or absence (-) of calf intestinal alkaline
phosphatase (AP). The combined effect of incorporation into lipids and hydrolysis of [14C]-
oleoyl-CoA lead to disappearance of 72 +/- 4.6 % of [14C]-oleoyl-CoA during incubation in all 4
cell lines, whether or not lyso-PA was added. C, lipids made by microsomes from 2.SLC4
cells either in the presence or absence of lyso-PA (2 μM) were deacylated with mild base
(NaOH)(+) or treated with PLA2 (+), or mock treated (-). Lipids were desalted and analyzed by
TLC in solvent 1 followed by radioimaging. The identity of the labeled lipids is indicated and
was obtained from the position of standards run in parallel, which either were radiolabeled,
could be revealed by iodine vapor or were elaborated in separate metabolic labeling experiments
using [3H]-inositol and [3H]-serine (not shown). No lipids got labeled when boiled microsomes
were used (not shown). The experiment is representative of several experiments showing similar
results.
Figure 4. Assay of O-acyltransferase activity in microsomes of 2.SLC4. A, 2.SLC4 were
grown either on glucose (YPDUA) or galactose (YPGUA) and microsomes were prepared. A,
microsomes, lyso-PA (50 μM final conc.) and [14C]-oleoyl-CoA were placed into reaction vials
on ice, vials were rapidly placed into a 25°C heating block and incubated for 0 to 64 min as
indicated, whereupon the reactions were stopped by the addition of organic solvent. The 0 min
vials received organic solvent after sitting 1 min on ice. The TLCs of this figure were developed
with solvent 2, so that PI, PC and PS are not well resolved and migrate in the zone denoted GPL;
o = origin. B, acyltransferase assays were set up with microsomes from 2.SLC4 grown on
YPGUA. Lanes 1 to 4, assays containing 2, 20 or 200 μg of microsomal protein and 50 μM lyso-
PA were incubated for 30 min; a control with boiled microsomes was run in lane 4. Lanes 5 –
16, lyso-PA concentrations of 0.05, 0.5, 5 or 50 μM were tested and assays were incubated for 1,
4 or 15 min. C, counts present in PA and GPLs on TLC plates shown in B were determined by
radioscanning.
Figure 5. Expression levels of Slc4 protein correlate with 1-acylglycerol-3-phosphate O-
acyltransferase activity in microsomes of 2.SLC4. A, microsomes were prepared from wt and
2.SLC4 cells grown on YPDUA (Glc) or YPGUA (Gal). Microsomes plus limiting amounts of
lyso-PA (1 μM final conc. = 0.6 mol%) were incubated for 0 - 64 min and lipid extracts were
analyzed by TLC in solvent 2. Only the zone of the TLC plate containing PA is shown. B, TLC
plates of the experiment shown in panel A as well as of an independent second experiment were












Figure 6. PA generated by Slc1p and Slc4p is metabolized to PI. The same microsomes as used
in Fig. 3 were incubated with [3H]-inositol in the standard assay mix containing CTP/Mg2+,
oleoyl-CoA and lyso-PA (complete) or in a mix where the ingredient indicated at the top was
lacking. TLC of the extracted lipids in solvent 1 showed a single radioactive band (for
illustration see supplemental Fig. S3). The counts obtained in PI when a reagent was omitted
relative to the counts obtained in the complete assay are indicated below each lane (% of
complete). About 5% of added [3H]-inositol was incorporated into PI in all microsomes when
the complete assay mixture was used.
Figure 7. Normal amounts of all major glycerophospholipid species are made in cells lacking
Slc1p or Slc4p. BY4742 wt cells, slc1, slc4, 2.SLC1 and 2.SLC4 cells were grown in
YPGUA at 30°C. Exponentially growing cells were harvested, lipid extracts were prepared,
were mixed with a fixed amount of lipid extract from wt cells grown in [13C]glucose, and were
analyzed by HPLC-ESI-MS/MS. A, in BY4742 wt cells the total ion counts were 4.999 x 106 for
PC, 0.302 x 106 for PE, 0.832 x 106 for PI, 0.103 x 106 for PG and 0.338 x 106 for PS. After
normalization using the internal standard, the corresponding figures for all lipid species in the
mutant cell lines were summed up and expressed as percentage of total ion counts in GPLs of
wt, which were set as 100%. B, in the same data set, the ion counts for each individual GPL
species of wt cells was set as 100% and the corrected ion counts for corresponding GPL species
in mutant cells depicted as percentage of ion counts in wt sample.
Figure 8. The fatty acid profile of major glycerophospholipid species in cells depending on only
Slc1p or only Slc4p are highly similar. From the experiment shown in Fig. 7, corrected ion
counts were utilized to calculate the relative abundance of the various forms defined by the
number of C atoms and double bonds present in the two fatty acids for all detectable GPL
species having a given head group. In each cell line, the total of all different forms of a given
GPL was taken as 100%. Data of panel B show X2180 wt cells grown at 24°C in YPD and are
taken from Fig. 6 of the report of Schneiter et al., (24), but are plotted in a way to be comparable
with other data in this figure.
Figure 9. Characterization of purified GST-Slc1p. A, the indicated amounts of protein of starting
yeast lysate (lanes 3, 4, 7, 8) and partially purified GST-Slc1p (lanes 1, 2, 5, 6) were analyzed by
SDS-PAGE/silver staining (lanes 1 - 4) and by Western blotting with antibody against
glutathione-S-transferase (GST) (lanes 5 - 8). The most prominent band in the purified fraction
is stained by anti-GST and is close to the expected molecular weight of 61'180 Da. B,
acyltransferase activity of purified GST-Slc1p was assayed with native (n) or boiled (b) enzyme
in the presence or absence of lyso-PA (50 μM) and Mg2+ (5 mM). In lane 7, Mg2+ was added
after incubation. C, GST-Slc1p was assayed with short incubations ranging from 3 to 30 min.
Quantitation of PA in the radiograms is shown in the graph below. D, acyltransferase activity of
purified GST-Slc1p was assayed with native (n) or boiled (b) enzyme (E) in the presence of
MgCl2 and 50 μM lyso-PA, lyso-PC, lyso-PS, lyso-PE or lyso-PI. In lanes 2 and 5, 1-palmitoyl-
and 1-stearoyl-2-hydroxy-sn-glycero-3-phosphate were used, respectively. Only 25% and 50%
of the reactions were spotted for samples containing lyso-PA and lyso-PS, respectively.
Radioscanning allowed to determine that the total amounts of product made from different
substrates were as follows: lyso-PA-C16 : 19’200 cpm, lyso-PA-C18 : 15’500 cpm, lyso-PC :
460 cpm, lyso-PE : 400 cpm, lyso-PS : 3’100 cpm, lyso-PI : 3’300 cpm. Lipids were analyzed by












Figure S1. Synthetic lethality of slc1 with slc4 and growth rates in liquid media. A,
slc1::KanMX4 (MATa) was crossed with slc4::KanMX4 (MAT), diploids were sporulated and
tetrads were dissected on YPDUA using standard procedures. Growing colonies were replicated
onto YPDUA supplemented with G418 to test for kanamycin resistance. In 22 tetrads, 6 were
parental ditypes (PD, 4 colonies, all resistant to kanamycine), 14 were tetratypes (T, 3 colonies,
2 resistant to kanamycin), and 2 were non-parental ditypes (NPD, two colonies, both sensitive to
kanamycin). The ratio of the various types (PD:NPD:T = 6:2:14) may indicate some centromeric
linkage of the two markers. Pictures of plates taken at regular intervals and comparison with the
genotypes showed that single mutant colonies have a normal growth rate on plates. B, cells were
grown in SGaa or SDaa at 30°C and their concentration was determined photometrically (A600).
Figure S2. Addition of lyso-PA blocks the incorporation of [14C]-oleate into GPLs in microsomes
from 2.SLC1 but not in microsomes from 2.SLC4. 2.SLC4 or 2.SLC1 cells were grown in
YPGUA and microsomes were prepared. Microsomes (135 μg of protein), [14C]-oleoyl-CoA
(0.05 μCi), without (-) or with (+) lyso-PA (50 μM final conc.), were incubated for 120 min.
Desalted lipid extracts were separated by TLC in solvent 2 and visualized by radioimaging.
Figure 3S. Complement to Figure 6. PI was the only lipid made in presence of [3H]-inositol and
CTP in all cell lines. For illustration the figure shows the TLC obtained for wt microsomes, of
which only a small zone is shown in Fig. 6. The counts obtained in PI when a reagent was
omitted relative to the counts obtained in the complete assay are indicated below each lane (% of
complete).
Figure 4S. Phosphatidic acid generated by Slc1p and Slc4p is metabolized to PS and PE. A and
B, microsomes from different strains used also in the experiment depicted in Fig. 3 were
incubated with [3H]-serine in the standard assay mix containing CTP/Mg2+, oleoyl-CoA and
lyso-PA (complete) or a mix wherein one of these additions had been omitted. Extracted lipids
were run on TLC and the bands corresponding to PS and PE were quantitated by radioscanning.
The counts obtained in PS or PE when a reagent was omitted relative to the counts obtained in
the complete assay are indicated below each lane (% of complete).
Figure S5. Phosphatidic acid made by Slc1p and Slc4p is used for synthesis of triacylglycerides.
Lipids were grown at 30°C until they reached the stationary phase in SDaaUA (SD), SGaaUA
(SG) or YPG as indicated. Lipids were extracted and samples corresponding to 20 A600 units of
cells were run on TLC in petroleum ether/diethyl ether/acetic acid (70:30:2) and visualized by
iodine vapor. 4 represents RSY3077 = are1 are2 lro1 dga1 (cells which are unable to
make triacylglycerides (TG)(Fig. 1) and were used as a negative control (lane 5). Depending on
the genotype of microsomes, between 0.5 and 1.5% of added [3H]-serine was incorporated into
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